Literature DB >> 28687148

99mTc-mebrofenin hepatobiliary scintigraphy predicts liver failure following major liver resection for perihilar cholangiocarcinoma.

Pim B Olthof1, Robert J S Coelen2, Roelof J Bennink3, Michal Heger2, Meng F Lam3, Marc G Besselink2, Olivier R Busch2, Krijn P van Lienden4, Thomas M van Gulik2.   

Abstract

BACKGROUND: Posthepatectomy liver failure (PHLF) is a threatening complication after liver surgery, especially in perihilar cholangiocarcinoma (PHC). This study aimed to assess the value of preoperative assessment of liver function using 99mTc-mebrofenin hepatobiliary scintigraphy (HBS) to predict PHLF in comparison with liver volume in PHC patients.
METHODS: All patients who underwent resection of suspected PHC in a single center between 2000 and 2015 were included in the analysis. PHLF was graded according to the ISGLS criteria with grade B/C considered clinically relevant. A cut-off value for the prediction of PHLF was calculated using the receiver operating characteristic curve (ROC) analysis.
RESULTS: A total of 116 patients were included of which 27 (23%) suffered of PHLF. ROC values for the prediction of PHLF were 0.74 (0.63-0.86) for future liver remnant function and 0.63 (0.47-0.80) for volume. A cut-off for liver function was set at 8.5%/min, which resulted in a negative predictive value of 94% and positive predictive value of 41%.
CONCLUSIONS: Assessment of liver function with HBS had better predictive value for PHLF than liver volume in patients undergoing major liver resection for suspected PHC. The cut-off of 8.5%/min can help to select patients for portal vein embolization and might help to reduce postoperative liver failure.
Copyright © 2017 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28687148     DOI: 10.1016/j.hpb.2017.05.007

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  20 in total

Review 1.  Liver regeneration biology: Implications for liver tumour therapies.

Authors:  Christopher Hadjittofi; Michael Feretis; Jack Martin; Simon Harper; Emmanuel Huguet
Journal:  World J Clin Oncol       Date:  2021-12-24

Review 2.  Value of Liver Function Tests in Cirrhosis.

Authors:  Praveen Sharma
Journal:  J Clin Exp Hepatol       Date:  2021-11-14

Review 3.  Optimization of the future remnant liver: review of the current strategies in Europe.

Authors:  Riccardo Memeo; Maria Conticchio; Emmanuel Deshayes; Silvio Nadalin; Astrid Herrero; Boris Guiu; Fabrizio Panaro
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

Review 4.  Current Modalities for the Assessment of Future Remnant Liver Function.

Authors:  Fadi Rassam; Pim B Olthof; Roelof J Bennink; Thomas M van Gulik
Journal:  Visc Med       Date:  2017-11-30

Review 5.  Evaluation of Liver Function and the Role of Biliary Drainage before Major Hepatic Resections.

Authors:  Yuzo Yamamoto
Journal:  Visc Med       Date:  2020-12-11

Review 6.  Surgical Therapy for Perihilar Cholangiocarcinoma: State of the Art.

Authors:  Lynn E Nooijen; Rutger-Jan Swijnenburg; Heinz-Josef Klümpen; Joanne Verheij; Geert Kazemier; Thomas M van Gulik; Joris I Erdmann
Journal:  Visc Med       Date:  2021-01-07

7.  Value of Preoperative Indocyanine Green Clearance Test for Predicting Post-Hepatectomy Liver Failure in Noncirrhotic Patients.

Authors:  Cem Ibis; Dogan Albayrak; Tayfun Sahiner; Yigit Soytas; Basak Gurtekin; Nukhet Sivrikoz
Journal:  Med Sci Monit       Date:  2017-10-18

8.  Maturity of associating liver partition and portal vein ligation for staged hepatectomy-derived liver regeneration in a rat model.

Authors:  Yi-Fan Tong; Ning Meng; Miao-Qin Chen; Han-Ning Ying; Ming Xu; Billy Lu; Jun-Jie Hong; Yi-Fan Wang; Xiu-Jun Cai
Journal:  World J Gastroenterol       Date:  2018-03-14       Impact factor: 5.742

9.  Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma.

Authors:  Pim B Olthof; Luca Aldrighetti; Ruslan Alikhanov; Matteo Cescon; Bas Groot Koerkamp; William R Jarnagin; Silvio Nadalin; Johann Pratschke; Moritz Schmelze; Ernesto Sparrelid; Hauke Lang; Alfredo Guglielmi; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2020-02-26       Impact factor: 5.344

10.  ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery-Portal Vein Embolization.

Authors:  Pim B Olthof; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2020-03-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.